Anti-Legalization Pharmaceutical Company Gets Schedule II Clearance for its Synthetic THC Drug – The Marijuana Times


The Marijuana Times
Anti-Legalization Pharmaceutical Company Gets Schedule II Clearance for its Synthetic THC Drug
The Marijuana Times
Last week, the pharmaceutical giant Insys Therapeutics scored a major victory when it was announced that their new synthetic THC drug – Syndros – was approved by the Drug Enforcement Administration for placement on Schedule II of the federal Controlled …

and more >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd